X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (19100) 19100
Book Review (6029) 6029
Publication (1292) 1292
Newsletter (370) 370
Book / eBook (226) 226
Book Chapter (77) 77
Conference Proceeding (53) 53
Magazine Article (18) 18
Newspaper Article (15) 15
Dissertation (7) 7
Reference (4) 4
Transcript (4) 4
Web Resource (3) 3
Paper (2) 2
Presentation (2) 2
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18063) 18063
humans (16882) 16882
female (8306) 8306
oncology (8233) 8233
male (6569) 6569
chemotherapy (5798) 5798
cancer (5632) 5632
middle aged (5237) 5237
antineoplastic combined chemotherapy protocols - therapeutic use (4840) 4840
antineoplastic agents - therapeutic use (4819) 4819
adult (4723) 4723
animals (4554) 4554
aged (4179) 4179
antineoplastic agents, alkylating - therapeutic use (4025) 4025
treatment outcome (3261) 3261
pharmacology & pharmacy (2540) 2540
antineoplastic agents (2537) 2537
hematology (2383) 2383
antineoplastic agents - pharmacology (2366) 2366
care and treatment (2364) 2364
combined modality therapy (2153) 2153
mice (2111) 2111
dacarbazine - analogs & derivatives (2036) 2036
antimitotic agents (2014) 2014
neoplasms - drug therapy (2014) 2014
medicine & public health (1893) 1893
prognosis (1835) 1835
antineoplastic agents, alkylating - administration & dosage (1781) 1781
therapy (1731) 1731
research (1712) 1712
antineoplastic agents - adverse effects (1673) 1673
dacarbazine - therapeutic use (1645) 1645
cell line, tumor (1639) 1639
temozolomide (1598) 1598
brain neoplasms - drug therapy (1536) 1536
cyclophosphamide (1529) 1529
antineoplastic combined chemotherapy protocols - adverse effects (1493) 1493
tumors (1493) 1493
antineoplastic agents - administration & dosage (1479) 1479
health aspects (1472) 1472
drug therapy (1435) 1435
radiotherapy (1411) 1411
apoptosis (1406) 1406
adolescent (1403) 1403
analysis (1396) 1396
disease-free survival (1319) 1319
retrospective studies (1318) 1318
cyclophosphamide - administration & dosage (1301) 1301
aged, 80 and over (1300) 1300
dose-response relationship, drug (1276) 1276
survival (1201) 1201
child (1194) 1194
antineoplastic agents, alkylating - adverse effects (1191) 1191
survival analysis (1170) 1170
abridged index medicus (1161) 1161
breast neoplasms - drug therapy (1123) 1123
survival rate (1104) 1104
clinical trials as topic (1073) 1073
cyclophosphamide - therapeutic use (1011) 1011
follow-up studies (1009) 1009
neoplasm staging (1005) 1005
time factors (1001) 1001
cisplatin (966) 966
glioblastoma (966) 966
hematology, oncology and palliative medicine (929) 929
antineoplastic agents, alkylating - pharmacology (921) 921
drug administration schedule (918) 918
apoptosis - drug effects (915) 915
drug resistance, neoplasm (913) 913
phase-ii trial (911) 911
clinical neurology (893) 893
risk factors (887) 887
toxicity (881) 881
glioblastoma - drug therapy (880) 880
breast cancer (861) 861
antineoplastic combined chemotherapy protocols - administration & dosage (854) 854
article (849) 849
phase-ii (841) 841
surgery (841) 841
transplantation (835) 835
multiple myeloma - drug therapy (831) 831
biochemistry & molecular biology (790) 790
expression (778) 778
trial (770) 770
rats (763) 763
cell survival - drug effects (760) 760
drug resistance (760) 760
leukemia (754) 754
drug therapy, combination (749) 749
child, preschool (744) 744
young adult (737) 737
in-vitro (733) 733
doxorubicin - administration & dosage (724) 724
breast-cancer (719) 719
chemotherapy, adjuvant (710) 710
glioma - drug therapy (704) 704
gliomas (704) 704
cells (703) 703
brain neoplasms - pathology (700) 700
cisplatin - administration & dosage (699) 699
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (157) 157
Collection Dvlpm't (Acquisitions) - Vendor file (14) 14
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (8) 8
Online Resources - Online (6) 6
Chemistry (A D Allen) - Stacks (3) 3
Gerstein Science - Circulation Desk (2) 2
Credit Valley Hospital - Stacks (1) 1
Earth Sciences (Noranda) - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19066) 19066
French (174) 174
German (127) 127
Japanese (107) 107
Russian (91) 91
Spanish (54) 54
Chinese (31) 31
Italian (30) 30
Polish (19) 19
Hungarian (14) 14
Czech (10) 10
Dutch (8) 8
Norwegian (8) 8
Serbian (4) 4
Swedish (4) 4
Bulgarian (3) 3
Hebrew (3) 3
Ukrainian (3) 3
Finnish (2) 2
Lithuanian (2) 2
Portuguese (2) 2
Croatian (1) 1
Korean (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA, ISSN 0098-7484, 12/2017, Volume 318, Issue 23, pp. 2306 - 2316
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10028, pp. 1629 - 1637
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9839, pp. 358 - 365
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 12/2015, Volume 314, Issue 23, pp. 2535 - 2543
Journal Article
Annals of oncology, ISSN 0923-7534, 2015, Volume 26, Issue 9, pp. 1994 - 1999
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9980, pp. 1873 - 1883
Summary Background Treatment for patients with chronic lymphocytic leukaemia who are elderly or who have comorbidities is challenging because fludarabine-based... 
Internal Medicine | BENDAMUSTINE | 1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | CLL | CYCLOPHOSPHAMIDE | CHEMOIMMUNOTHERAPY | RITUXIMAB | MONOCLONAL-ANTIBODIES | ELDERLY-PATIENTS | FLUDARABINE | HUMAN CD20 | Age Distribution | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Chlorambucil - adverse effects | Prospective Studies | Chlorambucil - therapeutic use | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents, Alkylating - administration & dosage | Aged, 80 and over | Adult | Female | Chlorambucil - administration & dosage | Drug Administration Schedule | Kaplan-Meier Estimate | Treatment Outcome | Antineoplastic Agents, Alkylating - therapeutic use | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sex Distribution | Aged | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Antineoplastic Agents, Alkylating - adverse effects | Chlorambucil | Medical colleges | Hospitals | Comorbidity | United Kingdom | Product development | India | Medical research | Flow cytometry | Immunoglobulins | Medical imaging | Laboratories | Cytotoxicity | Infections | Ovarian cancer | Bone marrow | Drug dosages | Age | Binding sites | Geriatrics | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1215 - 1223
Journal Article
Nature, ISSN 0028-0836, 11/2015, Volume 527, Issue 7579, pp. 472 - 476
The role of epithelial-to-mesenchymal transition (EMT) in metastasis is a longstanding source of debate, largely owing to an inability to monitor transient and... 
CANCER-CELLS | STEM-CELLS | THERAPY | MULTIDISCIPLINARY SCIENCES | RESISTANCE | INDUCTION | MODEL | MIR-200 FAMILY | EXPRESSION | BREAST | PLASTICITY | Lung Neoplasms - drug therapy | Apoptosis - drug effects | Antineoplastic Agents, Alkylating - pharmacology | Epithelial-Mesenchymal Transition - drug effects | Lung Neoplasms - pathology | Male | Epithelial-Mesenchymal Transition - genetics | Cyclophosphamide - therapeutic use | Mammary Neoplasms, Experimental - genetics | Cell Tracking | Lung Neoplasms - secondary | Neoplasm Metastasis - drug therapy | Mammary Neoplasms, Experimental - pathology | Female | Disease Models, Animal | Mammary Neoplasms, Experimental - drug therapy | Lung Neoplasms - genetics | Reproducibility of Results | Disease Progression | Antineoplastic Agents, Alkylating - therapeutic use | Cell Lineage | Neoplasm Metastasis - genetics | Drug Resistance, Neoplasm - genetics | Animals | Neoplasm Metastasis - pathology | Cyclophosphamide - pharmacology | Cell Proliferation - drug effects | Mice | MicroRNAs - genetics | Drug Resistance, Neoplasm - drug effects | Development and progression | Metastasis | Drug resistance | Cell differentiation | Health aspects | Lung cancer | Chemotherapy | Analysis | Stem cells | Cancer | Studies | Genotype & phenotype | Transgenic animals | Rodents | Morphology | Fibroblasts | Breast cancer | Cancer therapies | Tumors | Index Medicus
Journal Article
Journal Article